Bellicum Pharmaceuticals, Inc. (BLCM) Social Stream

Bellicum Pharmaceuticals, Inc. (BLCM): $1.38

0.01 (+0.73%)

POWR Rating

Component Grades













Add BLCM to Watchlist
Sign Up

Industry: Biotech


of 502

in industry

Bellicum Pharmaceuticals Inc (BLCM) Price Targets From Analysts

The tables below show the price targets and recommendations analysts covering BLCM.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2022-03-28 1 $5 $5 $5 $2.02 147.52%
NA 1 $NA $NA $NA $2.02 NA%

Price Target Last Issued March 28, 2022

The Trend in the Analyst Price Target

Over the past 22 months, BLCM's average price target has gone down $12.33.

Over the past 40 days, BLCM's average upside potential has been 190.93%.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-02-16 1 5 5 5 1.59 214.47%
2022-03-28 1 5 5 5 1.87 167.38%

BLCM Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 1 0 0 0 0 1

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • In the context of all US stocks, Bellicum Pharmaceuticals Inc's number of analysts covering the stock is greater than nearly none of them.
  • Bellicum Pharmaceuticals Inc's variance in analysts' estimates is lower than almost 100% of all US stocks.
  • To contextualize these metrics, consider that out of Pharmaceutical Products stocks, Bellicum Pharmaceuticals Inc's average analyst price target is higher than 5.44% of them.
  • Bellicum Pharmaceuticals Inc's upside potential (average analyst target price relative to current price) is greater than 63.88% of stocks in the small market cap category.

Stocks similar to Bellicum Pharmaceuticals Inc in the Pharmaceutical Products industry regarding analyst recommendations and price targets are BIVI, BCYC, and BCEL.

Is BLCM a Buy, Hold or Sell? See the POWR Ratings now!

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.533 seconds.